Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
ING Group ADR | ING | Nov 21, 2024 | 15.64 | -0.32 |
Ingersoll Rand | IR | Nov 21, 2024 | 103.04 | -0.07 |
Ingevity | NGVT | Nov 21, 2024 | 48.41 | +4.69 |
Ingles Markets A | IMKTA | Nov 21, 2024 | 70.33 | +1.25 |
Ingram Micro Holding Corp | INGM | Nov 21, 2024 | 21.47 | 0.00 |
Ingredion | INGR | Nov 21, 2024 | 144.36 | +1.41 |
Inhibikase Therapeutics | IKT | Nov 21, 2024 | 2.01 | +1.52 |
Inhibrx Biosciences | INBX | Nov 21, 2024 | 13.98 | -0.43 |
InMed Pharmaceuticals | INM | Nov 21, 2024 | 4.65 | +9.93 |
InMode | INMD | Nov 21, 2024 | 18.48 | +1.34 |
INmune Bio | INMB | Nov 21, 2024 | 4.76 | +4.39 |
Innate Pharma ADR | IPHA | Nov 21, 2024 | 1.70 | +0.86 |
Inno Holdings | INHD | Nov 21, 2024 | 5.06 | +2.02 |
Innodata | INOD | Nov 21, 2024 | 46.23 | +4.00 |
Innospec | IOSP | Nov 21, 2024 | 118.34 | +0.08 |
InnovAge | INNV | Nov 21, 2024 | 4.63 | -1.49 |
Innovate | VATE | Nov 21, 2024 | 4.82 | +23.91 |
Innovation Beverage Group | IBG | Nov 21, 2024 | 1.17 | 0.00 |
Innovative Eyewear | LUCY | Nov 21, 2024 | 6.72 | -1.75 |
Innovative Industrial Properties | IIPR | Nov 21, 2024 | 105.77 | +0.45 |
Innovative Industrial Properties A Pref | IIPR-A | Nov 21, 2024 | 26.42 | +0.27 |
Innovative Solutions and Support | ISSC | Nov 21, 2024 | 7.47 | -3.24 |
Innovex International | INVX | Nov 21, 2024 | 17.36 | 0.00 |
Innovid | CTV | Nov 21, 2024 | 3.01 | +85.80 |
Innoviva | INVA | Nov 21, 2024 | 19.06 | -0.47 |
Innoviz Technologies | INVZ | Nov 21, 2024 | 0.53 | +1.32 |
InnSuites Hospitality | IHT | Nov 21, 2024 | 2.04 | -0.10 |
Innventure | INV | Nov 21, 2024 | 10.66 | 0.00 |
Inogen | INGN | Nov 21, 2024 | 9.21 | -2.64 |
Inotiv | NOTV | Nov 21, 2024 | 3.41 | +6.23 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.